Clinical Trial Update: Research Study to Compare a New Medicine "Fast-acting Insulin Aspart" to Another Medicine "Insulin Aspart" in Chinese People With Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Fast-acting Insulin Aspart to Insulin Aspart in Chinese adults with Type 1 or Type 2 diabetes has completed, with results posted on Ma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Fast-acting Insulin Aspart (insulin aspart)
• Insulin aspart (insulin aspart)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2024-03-20